Fundraising Fox
Arvinas Holding Co. LLC
NASDAQ: ARVNNew Haven, US · Founded 2014 · Delaware corporation · 299 employees on LinkedIn · 9 known investors
Find your way into Arvinas Holding Co. LLC
Sign up to see every warm intro you have to Arvinas Holding Co. LLC
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Arvinas Holding Co. LLC team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Arvinas is a biopharmaceutical company developing PROTAC protein degrader therapies, with a pipeline focused on oncology and neurology. It advances preclinical research into clinical-stage treatments for patients with limited or ineffective existing options.
Founders & leadership
Board
Investors · 9
How we know: 5AM Ventures's portfolio page · a partner's Signal profile · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Access Biotechnology's portfolio page · Not right? Tell us
How we know: Canaan Partners's portfolio page · a partner's Signal profile · board seat on SEC Form D · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Connecticut Innovations's portfolio page · funding news · Not right? Tell us
How we know: Nextech Invest's portfolio page · a partner's Signal profile · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: RA Capital's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: open dataset · 5k.vc investor directory · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$129.1M disclosed across 3 of 5 rounds · 1900–2019
▶$32.5MraisedJul 2019 · 1 investors · BiotechnologyRule 506(b)
- John G. HoustonExecutive Officer, Director
- Sean CassidyExecutive Officer
- Bradley MargusDirector
- Kush ParmarDirector
- Timothy ShannonDirector
- Edward Kennedy, Jr.Director
- Briggs MorrisonDirector
- Liam RatcliffeDirector
- Jakob LovenDirector
- Ian TaylorExecutive Officer
- Offering amount
- $32.5M
- Amount sold
- $32.5M
- First sale
- Jul 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$55MraisedApr 2018 · 22 investors · BiotechnologyRule 506(b)
- Andrew LevinDirector
- Sean CassidyExecutive Officer
- Tim ShannonDirector
- Kush ParmarDirector
- Jakob LovenDirector
- Liam RatcliffeDirector
- Stephen SquintoDirector
- John D. HoustonExecutive Officer, Director
- Jonathan SoderstromDirector
- Brad MargusDirector
- Offering amount
- $55M
- Amount sold
- $55M
- First sale
- Mar 2018
- Incorporated
- Limited Liability Company, Delaware, 2014
- Federal exemptions
- 06b
▶$41.6MraisedOct 2015 · 16 investors · BiotechnologyRule 506(b)
- Stephen SquintoDirector
- Liam RatcliffeDirector
- Andrew LevinDirector
- Sean CassidyExecutive Officer
- Tim ShannonDirector
- Jonathan SoderstromDirector
- Brad MargusDirector
- Manuel LitchmanExecutive Officer, Director
- Kush ParmarDirector
- Offering amount
- $41.6M
- Amount sold
- $41.6M
- First sale
- Oct 2015
- Incorporated
- Limited Liability Company, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
5 people who came through Arvinas Holding Co. LLC went on to found or lead other companies.
Related companies · 1
Companies working in the same space as Arvinas Holding Co. LLC.
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2016 | $1.1M |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Arvinas Holding Co. LLC do?
- Arvinas is a biopharmaceutical company developing PROTAC protein degrader therapies, with a pipeline focused on oncology and neurology. It advances preclinical research into clinical-stage treatments for patients with limited or ineffective existing options.
- Who are Arvinas Holding Co. LLC's investors?
- Arvinas Holding Co. LLC's investors include 5AM Ventures, Access Biotechnology, Canaan Partners, Connecticut Innovations, Nextech Invest, RA Capital, Solasta Ventures, Elm Street Ventures and 1 more.
- How much funding has Arvinas Holding Co. LLC raised?
- Arvinas Holding Co. LLC has disclosed $129.1M raised across 3 of its 5 known rounds.
- Where is Arvinas Holding Co. LLC headquartered?
- Arvinas Holding Co. LLC is headquartered in New Haven, US.